GSTM2 and colorectal cancer: The results revealed that compared with certain cells from normal tissues, GSTM2 expression was statistically reduced in stem cells (p = 0.008), and had a decreasing trend in fibroblasts (p = 0.311) and B cells (p = 0.13) from colorectal cancer tissues (Supplementary Table S4).